Published in Mod Pathol on July 29, 2011
Protocol for the examination of specimens from patients with pheochromocytomas and extra-adrenal paragangliomas. Arch Pathol Lab Med (2014) 2.31
German Association of Endocrine Surgeons practice guideline for the surgical management of malignant thyroid tumors. Langenbecks Arch Surg (2013) 1.23
The miR-221/222 cluster, miR-10b and miR-92a are highly upregulated in metastatic minimally invasive follicular thyroid carcinoma. Int J Oncol (2013) 0.97
The prognostic significance of lymphovascular invasion in patients with resectable gastric cancer: a large retrospective study from Southern China. BMC Cancer (2015) 0.84
When thyroid carcinoma goes bad: a morphological and molecular analysis. Head Neck Pathol (2015) 0.83
Evaluation of the WHO 2010 grading and AJCC/UICC staging systems in prognostic behavior of intestinal neuroendocrine tumors. PLoS One (2013) 0.83
Stromal modulation of bladder cancer-initiating cells in a subcutaneous tumor model. Am J Cancer Res (2012) 0.82
Prognostic impact of extent of vascular invasion in low-grade encapsulated follicular cell-derived thyroid carcinomas: a clinicopathologic study of 276 cases. Hum Pathol (2015) 0.81
Minimally invasive follicular thyroid cancer (MIFTC)--a consensus report of the European Society of Endocrine Surgeons (ESES). Langenbecks Arch Surg (2014) 0.81
Vascular invasion as an independent predictor of poor prognosis in nonmetastatic gastric cancer after curative resection. Int J Clin Exp Pathol (2015) 0.77
Diagnosis and management of parathyroid cancer. Nat Rev Endocrinol (2012) 0.76
Prognostic value of vascular invasion in well-differentiated papillary thyroid carcinoma. Thyroid (2015) 0.75
Relationship between lymphovascular invasion and clinicopathological features of papillary thyroid carcinoma. Bosn J Basic Med Sci (2017) 0.75
Loss of Kaiso expression in breast cancer cells prevents intra-vascular invasion in the lung and secondary metastasis. PLoS One (2017) 0.75
The 2004 World Health Organization classification of pituitary tumors: what is new? Acta Neuropathol (2005) 6.43
Pathogenetic mechanisms in thyroid follicular-cell neoplasia. Nat Rev Cancer (2006) 3.83
The prevalence of pituitary adenomas: a systematic review. Cancer (2004) 2.98
American Thyroid Association guidelines for management of patients with anaplastic thyroid cancer. Thyroid (2012) 2.71
Primary frozen section diagnosis by robotic microscopy and virtual slide telepathology: the University Health Network experience. Hum Pathol (2009) 2.54
Protocol for the examination of specimens from patients with pheochromocytomas and extra-adrenal paragangliomas. Arch Pathol Lab Med (2014) 2.31
Ikaros isoforms in human pituitary tumors: distinct localization, histone acetylation, and activation of the 5' fibroblast growth factor receptor-4 promoter. Am J Pathol (2003) 2.29
Interobserver and intraobserver variation among experts in the diagnosis of thyroid follicular lesions with borderline nuclear features of papillary carcinoma. Am J Clin Pathol (2008) 2.21
Observer variation in the diagnosis of follicular variant of papillary thyroid carcinoma. Am J Surg Pathol (2004) 2.08
Thyroid calcification and its association with thyroid carcinoma. Head Neck (2002) 1.70
Somatic mutation of CDKN1B in small intestine neuroendocrine tumors. Nat Genet (2013) 1.56
The melanoma-associated antigen A3 mediates fibronectin-controlled cancer progression and metastasis. Cancer Res (2008) 1.53
EWSR1-ATF1 fusion is a novel and consistent finding in hyalinizing clear-cell carcinoma of salivary gland. Genes Chromosomes Cancer (2011) 1.50
Pseudopheochromocytoma of pregnancy. Endocr Pract (2003) 1.45
The cancer-associated FGFR4-G388R polymorphism enhances pancreatic insulin secretion and modifies the risk of diabetes. Cell Metab (2013) 1.45
Pulmonary pathology of severe acute respiratory syndrome in Toronto. Mod Pathol (2005) 1.41
Growth enhancement in suppressor of cytokine signaling 2 (SOCS-2)-deficient mice is dependent on signal transducer and activator of transcription 5b (STAT5b). Mol Endocrinol (2002) 1.39
"Next-generation" pathology and laboratory medicine. Arch Pathol Lab Med (2011) 1.38
Rationale and evidence for sunitinib in the treatment of malignant paraganglioma/pheochromocytoma. J Clin Endocrinol Metab (2008) 1.37
Fibroblast growth factor receptors as molecular targets in thyroid carcinoma. Endocrinology (2004) 1.31
Distinct gene expression phenotypes of cells lacking Rb and Rb family members. Cancer Res (2003) 1.26
Retracted Targeted expression of a human pituitary tumor-derived isoform of FGF receptor-4 recapitulates pituitary tumorigenesis. J Clin Invest (2002) 1.24
XB130, a novel adaptor protein, promotes thyroid tumor growth. Am J Pathol (2010) 1.21
Application of immunohistochemistry to thyroid neoplasms. Arch Pathol Lab Med (2008) 1.20
Carney complex with adrenal cortical carcinoma. J Clin Endocrinol Metab (2011) 1.19
Fatal severe acute respiratory syndrome is associated with multiorgan involvement by coronavirus. J Infect Dis (2004) 1.18
Epigenetically controlled fibroblast growth factor receptor 2 signaling imposes on the RAS/BRAF/mitogen-activated protein kinase pathway to modulate thyroid cancer progression. Cancer Res (2007) 1.16
Severe acute respiratory syndrome-associated coronavirus in lung tissue. Emerg Infect Dis (2004) 1.16
Lack of prolactin receptor signaling in mice results in lactotroph proliferation and prolactinomas by dopamine-dependent and -independent mechanisms. J Clin Invest (2002) 1.15
A high-throughput proteomic approach provides distinct signatures for thyroid cancer behavior. Clin Cancer Res (2011) 1.14
Intratumoral lymphatics and lymph node metastases in papillary thyroid carcinoma. Arch Otolaryngol Head Neck Surg (2003) 1.14
Papillary thyroid carcinoma: an overview. Arch Pathol Lab Med (2006) 1.13
Clinicopathological correlations in pituitary adenomas. Brain Pathol (2012) 1.12
Correlation of biochemical parameters with single parathyroid adenoma weight and volume. Head Neck (2002) 1.07
Overexpression of cyclin D1 and underexpression of p27 predict lymph node metastases in papillary thyroid carcinoma. J Clin Endocrinol Metab (2002) 1.06
Vitamin D arrests thyroid carcinoma cell growth and induces p27 dephosphorylation and accumulation through PTEN/akt-dependent and -independent pathways. Am J Pathol (2002) 1.05
Mechanisms of disease: The pathogenesis of pituitary tumors. Nat Clin Pract Endocrinol Metab (2006) 1.02
Follicular variant papillary thyroid carcinoma arising in struma ovarii. Endocr Pathol (2007) 1.02
The implication of somatotroph adenoma phenotype to somatostatin analog responsiveness in acromegaly. J Clin Endocrinol Metab (2005) 1.01
Histone-acetylated control of fibroblast growth factor receptor 2 intron 2 polymorphisms and isoform splicing in breast cancer. Mol Endocrinol (2009) 1.00
Enhanced B-Raf protein expression is independent of V600E mutant status in thyroid carcinomas. Hum Pathol (2007) 1.00
Overexpression of HMGA2 relates to reduction of the let-7 and its relationship to clinicopathological features in pituitary adenomas. Mod Pathol (2009) 0.99
Epigenetic silencing through DNA and histone methylation of fibroblast growth factor receptor 2 in neoplastic pituitary cells. Am J Pathol (2007) 0.99
Controversies in thyroid pathology: thyroid capsule invasion and extrathyroidal extension. Ann Surg Oncol (2009) 0.98
Biomarkers of aggressive pituitary adenomas. J Mol Endocrinol (2012) 0.97
Composite adenomatoid tumor and myelolipoma of adrenal gland: report of 2 cases. Arch Pathol Lab Med (2008) 0.97
The cancer/testis antigen melanoma-associated antigen-A3/A6 is a novel target of fibroblast growth factor receptor 2-IIIb through histone H3 modifications in thyroid cancer. Clin Cancer Res (2007) 0.96
Cyclin D1 protein expression predicts metastatic behavior in thyroid papillary microcarcinomas but is not associated with gene amplification. J Clin Endocrinol Metab (2002) 0.96
Inactivation of RASSF1A tumor suppressor gene by aberrant promoter hypermethylation in human pituitary adenomas. Lab Invest (2005) 0.96
Fibroblast growth factor 2 and estrogen control the balance of histone 3 modifications targeting MAGE-A3 in pituitary neoplasia. Clin Cancer Res (2008) 0.96
Peptide-activated double-negative T cells can prevent autoimmune type-1 diabetes development. Eur J Immunol (2007) 0.96
Dual inhibition of RET and FGFR4 restrains medullary thyroid cancer cell growth. Clin Cancer Res (2005) 0.95
Pituitary tumor AP-2alpha recognizes a cryptic promoter in intron 4 of fibroblast growth factor receptor 4. J Biol Chem (2003) 0.95
Fibroblast growth factor receptor 4 is a target for the zinc-finger transcription factor Ikaros in the pituitary. Mol Endocrinol (2002) 0.94
The FGFR4-G388R polymorphism promotes mitochondrial STAT3 serine phosphorylation to facilitate pituitary growth hormone cell tumorigenesis. PLoS Genet (2011) 0.92
Tumor-specific downregulation and methylation of the CDH13 (H-cadherin) and CDH1 (E-cadherin) genes correlate with aggressiveness of human pituitary adenomas. Mod Pathol (2007) 0.92
The FGFR4-G388R single-nucleotide polymorphism alters pancreatic neuroendocrine tumor progression and response to mTOR inhibition therapy. Cancer Res (2012) 0.92
Controversies in papillary microcarcinoma of the thyroid. Endocr Pathol (2003) 0.91
Completion thyroidectomy versus total thyroidectomy: is there a difference in complication rates? An analysis of 350 patients. J Am Coll Surg (2007) 0.91
Precursor lesions of endocrine system neoplasms. Pathology (2013) 0.90
Non-pheochromocytoma (PCC)/paraganglioma (PGL) tumors in patients with succinate dehydrogenase-related PCC-PGL syndromes: a clinicopathological and molecular analysis. Eur J Endocrinol (2013) 0.90
Utilization of ancillary studies in thyroid fine needle aspirates: a synopsis of the National Cancer Institute Thyroid Fine Needle Aspiration State of the Science Conference. Diagn Cytopathol (2008) 0.90
Vitamin D3 administration induces nuclear p27 accumulation, restores differentiation, and reduces tumor burden in a mouse model of metastatic follicular thyroid cancer. Endocrinology (2004) 0.90
Aldosterone-producing adrenal cortical adenoma with oncocytic change and cytoplasmic eosinophilic globular inclusions. Endocr Pathol (2009) 0.90
Postnatal ablation of POMC neurons induces an obese phenotype characterized by decreased food intake and enhanced anxiety-like behavior. Mol Endocrinol (2013) 0.90
Pituitary tumor-derived fibroblast growth factor receptor 4 isoform disrupts neural cell-adhesion molecule/N-cadherin signaling to diminish cell adhesiveness: a mechanism underlying pituitary neoplasia. Mol Endocrinol (2004) 0.89
Loss of membrane localization and aberrant nuclear E-cadherin expression correlates with invasion in pancreatic endocrine tumors. Am J Surg Pathol (2008) 0.89
Ikaros integrates endocrine and immune system development. J Clin Invest (2005) 0.89
Myostatin is a skeletal muscle target of growth hormone anabolic action. J Clin Endocrinol Metab (2003) 0.88
Oncocytes, oxyphils, Hürthle, and Askanazy cells: morphological and molecular features of oncocytic thyroid nodules. Endocr Pathol (2010) 0.88
Tumor-derived Ikaros 6 acetylates the Bcl-XL promoter to up-regulate a survival signal in pituitary cells. Mol Endocrinol (2006) 0.88
Targeting N-cadherin through fibroblast growth factor receptor-4: distinct pathogenetic and therapeutic implications. Mol Endocrinol (2006) 0.88
Cytoplasmic expression of fibroblast growth factor receptor-4 in human pituitary adenomas: relation to tumor type, size, proliferation, and invasiveness. J Clin Endocrinol Metab (2004) 0.88
Osteopontin (OPN) expression in thyroid carcinoma. Anticancer Res (2010) 0.88
Spindle cell oncocytomas and granular cell tumors of the pituitary are variants of pituicytoma. Am J Surg Pathol (2013) 0.88
Retracted Genetic and epigenetic mechanisms down-regulate FGF receptor 2 to induce melanoma-associated antigen A in breast cancer. Am J Pathol (2010) 0.87
Deoxyribonucleic acid methyltransferase 3B promotes epigenetic silencing through histone 3 chromatin modifications in pituitary cells. J Clin Endocrinol Metab (2008) 0.87
FGFR2 isoforms support epithelial-stromal interactions in thyroid cancer progression. Cancer Res (2012) 0.87
Plurihormonality in pituitary adenomas associated with acromegaly. Endocr Pathol (2006) 0.87
Ectopic ACTH syndrome: discrepancy between somatostatin receptor status in vivo and ex vivo, and between immunostaining and gene transcription for POMC and CRH. Horm Res (2002) 0.87
Solitary fibrous tumor of the sella mimicking pituitary adenoma: an uncommon tumor in a rare location-a case report. Endocr Pathol (2009) 0.86
1alpha,25-Dihydroxyvitamin D3 targets PTEN-dependent fibronectin expression to restore thyroid cancer cell adhesiveness. Mol Endocrinol (2005) 0.85
Medullary thyroid carcinoma metastatic to the pituitary gland: an unusual site of metastasis. Ann Diagn Pathol (2007) 0.85
The zinc finger Ikaros transcription factor regulates pituitary growth hormone and prolactin gene expression through distinct effects on chromatin accessibility. Mol Endocrinol (2004) 0.85
Prolonged gastrointestinal transit in a patient with a glucagon-like peptide (GLP)-1- and -2-producing neuroendocrine tumor. J Clin Endocrinol Metab (2002) 0.84
Prediction of malignant behavior of pheochromocytomas and paragangliomas using immunohistochemical techniques. Endocr Pathol (2002) 0.84
Acromegaly and somatotroph hyperplasia with adenomatous transformation due to pituitary metastasis of a growth hormone-releasing hormone-secreting pulmonary endocrine carcinoma. J Clin Endocrinol Metab (2006) 0.84
The breast cancer susceptibility gene product fibroblast growth factor receptor 2 serves as a scaffold for regulation of NF-κB signaling. Mol Cell Biol (2012) 0.84
Biomarkers of parathyroid carcinoma. Endocr Pathol (2012) 0.83
Defining diagnostic tissue in the era of personalized medicine. CMAJ (2012) 0.83
The predictive value of CK19 and CD99 in pancreatic endocrine tumors. Am J Surg Pathol (2006) 0.83
When thyroid carcinoma goes bad: a morphological and molecular analysis. Head Neck Pathol (2015) 0.83
Primary frozen section diagnosis by robotic microscopy and virtual slide telepathology: the University Health Network experience. Semin Diagn Pathol (2009) 0.83
Clinical features of silent corticotroph adenomas. Acta Neurochir (Wien) (2012) 0.83
Familial pheochromocytoma and renal cell carcinoma syndrome: TMEM127 as a novel candidate gene for the association. Virchows Arch (2015) 0.83
Evaluation of the WHO 2010 grading and AJCC/UICC staging systems in prognostic behavior of intestinal neuroendocrine tumors. PLoS One (2013) 0.83
Hürthle cell tumors: using molecular techniques to define a novel classification system. Arch Otolaryngol Head Neck Surg (2002) 0.82
AIP Mutations are not identified in patients with sporadic pituitary adenomas. Endocr Pathol (2007) 0.82
Underexpression of p27/Kip in thyroid papillary microcarcinomas with gross metastatic disease. Arch Otolaryngol Head Neck Surg (2002) 0.82
Complex endocrinopathies in MEN-1: diagnostic dilemmas in endocrine oncology. Endocr Pathol (2007) 0.82